Clinical trial
Identification and Treatment of the Liability to Develop Schizophrenia
NCT00305474 · Central South University, Other · Unknown status
Key facts
| NCT number | NCT00305474 |
|---|---|
| Title | Identification and Treatment of the Liability to Develop Schizophrenia |
| Official title | Identification and Treatment of the Liability to Develop Schizophrenia |
| Lead sponsor | Central South University, Other |
| Collaborators | Ortho-McNeil Janssen Scientific Affairs, LLC Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 100 |
| Start date | Dec 1, 2003 |
| Primary completion | Jan 1, 2010 |
| First posted | Mar 22, 2006 |
| Last update posted | Jun 24, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: